**3. Conclusion**

Surely we are facing a new era of treatment in the new field of what is called regenerative medicine with an extraordinary range of possibilities for clinical applications increased, but that requires a process of scientific and medical systematization which allows channel it safely and effectively in applications where there is scientific evidence really enough weight so apply. To do this it is necessary to two things: first the consensus of the authors engaged in the production and application of this therapy in order to standardize procedures for obtaining those more effective and allow adequate traceability and monitoring of the end product, depending clinical application given their intended and secondly the design of clinical trials which management and establish appropriate guidelines to that effect.

Today we are still far from achieve, given that almost all existing clinical applications, the scientific evidence is weak, based on case series or case-control studies in the most positive assumptions. The growing presence of various protocols to obtain, low control over the final product component and variety of clinical applications, difficult first reach some sort of consensus on the process or procedures more reliable and adequate collection and secondly development of appropriate clinical trials to test them in different pathologies susceptible to it.

Revised everything published about the conclusion you reach is that the PRP is well tolerated technique, considered from 2 years as a medicine ago, restricted its use to prescribing physicians, dentists and podiatrists, lacking tab Currently technique, and cannot be considered standard treatment for any medical condition where intended to be used, if it is accepted that it can be used as adjunctive therapy along with conventional therapies to implement clinical and functional improvement of the patient.

They are necessary in the future of basic research and translational medicine to better understand the pathophysiological mechanisms underlying its regenerative effects.

[10] Fillardo G, Presti M, Kon E, Marcacci M. Nonoperative biological treatment approach

Clinical Applications of Plasma Growth Factors http://dx.doi.org/10.5772/intechopen.76089 95

[11] Ventura A, Erzaghi CT, Borgo E, Verdoia C, Gallazzi M, Failoni S. Use of growth factors

[12] Castricini R, Longo U, De Benedetto M, Panfolini N, Pirani P, Zini R, Maffulli N, Denaro V. Platelet-rich plasma augmentation for arthroscopic rotator cuff reapair: A randomized controlled trial. The American Journal of Sports Medicine. Feb 2011;**39**(2):258-265

[13] Jo C, Kim J, Yoon K, Lee J, Kang S, Lee J, Hans H, Rhee S, Shin S. Does platelet-rich plasma accelerate recovery after rotator cuff repair? A prospective cohort study. The

[14] Gamradt S, Rodeo S, Rusell F. Platelet rich plasma in rotator cuff repair. Techniques in

[15] Saito M, Takahashi K, Arai Y, Inoue A, Sakao K, Tonomura H, Honjo K, Nakagawa S, Inoue H, Tabata Y, Kubo T. Intrarticular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the

[16] Sampson S, Reed M, Silvers H, Meng M, Mandelbaum B. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis. American Journal of

[17] Appel T, Potzsch B, Muller J, von Lindern J, Berge SJ, Reich RH. Comparison of three different preparations of platelet concentrates for growth factor enrichment. Clinical Oral

[18] Glazer J. An approach to the diagnosis and treatment of plantar fasitis. The Physician

[19] Dimauro I, Grasso L, Fittipaldi S, Fantani C, Mercatelli N, Racca S, Geuna S, Di Gianfrancesco A, Caporossi D, Pigozzi F, Borrione P. Platelet-rich plasma and skeletal muscle healing: A molecular analysis of the early phases of the regeneration process in an experimental animal model. PLoS One. 2014 Jul 23;**9**(7):e102993. DOI: 10.1371.eCol-

[20] Marx R, Garg A. The biology of platelets and the mechanism of platelet-rich plasma. En: Marx R, Garg A, Editores. Dental and Craneofacial Applications of PRP. Quintessence

[21] Luces G, García LA. Uso del Plasma Rico en Plaquetas Para la regeneración Tisular en la Terapia Periodontal. Caracas: Universidad central de Venezuela. Tésis monográficas;

[22] Spector M. Basic principles of tissue Engeneering. Tissue Engeneering: Applications in Maxillofacial Surgery and Periodontics. Editorial: Quintessense Books. 1999. Illinois-

for partial Aquilles tendon lesion. Orthopedics. 2010;**1**(33):120-123

American Journal of Sports Medicine. Oct 2011;**39**(10):2082-2090

rabbit knee. Clinical and Experimental Rheumatology. 2009;**2**:27

Physical Medicine & Rehabilitation. 2010;**89**:961-969

Orthopaedics. 2007;**22**(1):26-33

Implants Research. 2002;**13**:522-528

and Sportsmedicine. 2009;**37**(2):74-79

Publishing Co, Inc.: Chicago; 2005. pp. 3-65

lection 2014

2006

Estados Unidos

in ACL surgery. Journal of Orthopaedics and Traumatology. 2005;**6**:76-70

Similarly sheet to establish a sound scientific studies are necessary in the form of clinical trials to standardize the techniques for obtaining both depending on the cellular composition of the final product as a protein obtained and is reproducible by all authors and specific management guidelines for each clinical application where feasible use in regenerative medicine.
